Venus Concept (VERO) 10-Q 13 Nov 24 2024 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2024	Nov. 07, 2024
Document Information [Line Items]
Entity Central Index Key	0001409269
Entity Registrant Name	Venus Concept Inc.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-38238
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	06-1681204
Entity Address, Address Line One	235 Yorkland Blvd., Suite 900
Entity Address, City or Town	Toronto
Entity Address, State or Province	ON
Entity Address, Postal Zip Code	M2J 4Y8
City Area Code	877
Local Phone Number	848-8430
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	VERO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		7,255,277

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 4,489	$ 5,396
Accounts receivable, net of allowance of $4,133 and $7,415 as of September 30, 2024, and December 31, 2023, respectively	21,102	29,151
Inventories	18,904	23,072
Prepaid expenses	1,002	1,298
Advances to suppliers	4,508	5,604
Other current assets	1,213	1,925
Total current assets	51,218	66,446
LONG-TERM ASSETS:
Long-term trade receivables	8,865	11,318
Deferred tax assets	1,292	1,032
Severance pay funds	426	573
Property and equipment, net	1,038	1,322
Operating right-of-use assets, net	3,591	4,517
Intangible assets	5,846	8,446
Total long-term assets	21,058	27,208
TOTAL ASSETS	72,276	93,654
CURRENT LIABILITIES:
Trade payables	7,120	9,038
Accrued expenses and other current liabilities	10,674	12,437
Note payable	4,389	0
Current portion of long-term debt	200	4,155
Income taxes payable	663	366
Unearned interest income	1,027	1,468
Warranty accrual	1,072	1,029
Deferred revenues	915	1,076
Operating lease liabilities	1,407	1,590
Total current liabilities	27,467	31,159
LONG-TERM LIABILITIES:
Long-term debt	30,025	70,790
Accrued severance pay	464	634
Deferred tax liabilities	0	15
Unearned interest revenue	394	671
Warranty accrual	269	334
Operating lease liabilities	2,333	3,162
Other long-term liabilities	696	338
Total long-term liabilities	34,181	75,944
TOTAL LIABILITIES	61,648	107,103
Commitments and Contingencies (Note 9)
STOCKHOLDERS’ EQUITY (DEFICIT) (Note 15):
Common Stock, $0.0001 par value: 300,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 7,255,277 and 5,529,149 issued and outstanding as of September 30, 2024, and December 31, 2023, respectively	30	30
Additional paid-in capital	311,012	247,854
Accumulated deficit	(300,934)	(261,903)
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)	10,108	(14,019)
Non-controlling interests	520	570
Equity, Including Portion Attributable to Noncontrolling Interest	10,628	(13,449)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$ 72,276	$ 93,654

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Accounts receivable, allowance, current	$ 4,133	$ 7,415
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares issued (in shares)	7,255,277	5,529,149
Common stock, shares outstanding (in shares)	7,255,277	5,529,149

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues	$ 15,007	$ 17,616	$ 49,068	$ 58,222
Cost of goods sold:
Cost of goods and services sold	5,086	5,431	15,651	18,118
Gross profit	9,921	12,185	33,417	40,104
Operating expenses:
Selling and marketing	6,654	6,907	21,076	23,319
General and administrative	8,732	10,115	27,640	30,933
Research and development	1,692	1,925	5,214	6,527
Total operating expenses	17,078	18,947	53,930	60,779
Loss from operations	(7,157)	(6,762)	(20,513)	(20,675)
Other expenses:
Foreign exchange loss	57	909	1,155	379
Finance expenses	1,665	1,605	5,785	4,666
Loss on disposal of subsidiaries	0	1	0	77
Loss on extinguishment of debt	454	0	11,355	0
Loss before income taxes	(9,333)	(9,277)	(38,808)	(25,797)
Income tax (benefit) expense	(31)	(321)	147	103
Net loss	(9,302)	(8,956)	(38,955)	(25,900)
Loss attributable to stockholders of the Company	(9,286)	(9,068)	(39,031)	(26,134)
Net income — non-controlling interest	$ (16)	$ 112	$ 76	$ 234
Net loss per share:
Basic (in dollars per share)	$ (1.28)	$ (1.64)	$ (5.96)	$ (4.83)
Diluted (in dollars per share)	$ (1.28)	$ (1.64)	$ (5.96)	$ (4.83)
Weighted-average number of shares used in per share calculation:
Basic (in shares)	7,255	5,527	6,547	5,413
Diluted (in shares)	7,255	5,527	6,547	5,413
Leases [Member]
Revenues	$ 2,684	$ 4,368	$ 10,732	$ 14,440
Cost of goods sold:
Cost of goods and services sold	651	1,183	2,538	3,633
Products and Services [Member]
Revenues	12,323	13,248	38,336	43,782
Cost of goods sold:
Cost of goods and services sold	$ 4,435	$ 4,248	$ 13,113	$ 14,485

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net loss	$ (9,302)	$ (8,956)	$ (38,955)	$ (25,900)
Loss attributable to stockholders of the Company	(9,286)	(9,068)	(39,031)	(26,134)
Income (loss) attributable to non-controlling interest	(16)	112	76	234
Comprehensive loss	$ (9,302)	$ (8,956)	$ (38,955)	$ (25,900)

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member] The 2022 Private Placement [Member]		Preferred Stock [Member] Multi-Tranche Private Placement 2023 [Member]	Preferred Stock [Member] The 2023 Series X Private Placement [Member]	Preferred Stock [Member] The 2024 Series Y Private Placement [Member]	Common Stock [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2022	3,185,000	[1]	0				5,161,374
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022						$ 0		$ 0		$ (548)		$ 0
Balance at Dec. 31, 2022							$ 29		$ 232,169		$ (224,105)		$ 645
Issuance of common stock (in shares)	0	[1]	0				224,378
Issuance of common stock							$ 1		744		0		0
Net loss — the Company							0		0		(9,657)		0
Net income — non-controlling interest							0		0		0		34
Stock-based compensation							$ 0		481		0		0
Restricted share units vested (in shares)	0		0				22,000
Restricted share units vested									0		0		0
Balance (in shares) at Mar. 31, 2023	3,185,000	[1]	0				5,407,752
Balance at Mar. 31, 2023							$ 30		233,394		(234,310)		679
Balance (in shares) at Dec. 31, 2022	3,185,000	[1]	0				5,161,374
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022						$ 0		$ 0		$ (548)		$ 0
Balance at Dec. 31, 2022							$ 29		232,169		(224,105)		645
Net income — non-controlling interest														$ 234
Balance (in shares) at Sep. 30, 2023	3,185,000	[1]	1,073,297				5,529,149
Balance at Sep. 30, 2023							$ 30		238,587		(250,787)		792
Balance (in shares) at Mar. 31, 2023	3,185,000	[1]	0				5,407,752
Balance at Mar. 31, 2023							$ 30		233,394		(234,310)		679
Issuance of common stock (in shares)	0		0				118,729
Issuance of common stock							$ 0		71		0		0
2024 Registered Direct Offering shares and warrants, net of costs (in shares)	0		280,899				0
2024 Registered Direct Offering shares and warrants, net of costs							$ 0		1,206		0		0
Net loss — the Company							0		0		(7,409)		0
Net income — non-controlling interest							0		0		0		88
Stock-based compensation							0		369		0		0
Dividends from subsidiaries							0		0		0		(87)
Beneficial conversion feature							$ 0		427		0		0
Balance (in shares) at Jun. 30, 2023	3,185,000	[1]	280,899				5,526,481
Balance at Jun. 30, 2023							$ 30		235,467		(241,719)		680
2024 Registered Direct Offering shares and warrants, net of costs (in shares)	0		792,398				0
2024 Registered Direct Offering shares and warrants, net of costs							$ 0		1,524		0		0
Net loss — the Company							0		0		(9,068)		0
Net income — non-controlling interest							0		0		0		112	112
Stock-based compensation							$ 0		364		0		0
Restricted share units vested (in shares)	0		0				2,668
Restricted share units vested							$ 0		0		0		0
Beneficial conversion feature							$ 0		1,232		0		0
Balance (in shares) at Sep. 30, 2023	3,185,000	[1]	1,073,297				5,529,149
Balance at Sep. 30, 2023							$ 30		238,587		(250,787)		792
Balance (in shares) at Dec. 31, 2023	3,185,000		1,575,810	256,356	0		5,529,149
Balance at Dec. 31, 2023							$ 30		247,854		(261,903)		570	(13,449)
Issuance of common stock (in shares)	0		0	0	0		8,333
Issuance of common stock									10		0		0	10
2024 Registered Direct Offering shares and warrants, net of costs (in shares)	0		0	0	0		817,748
2024 Registered Direct Offering shares and warrants, net of costs							$ 0		977		0		0	977
2023 Series X Private Placement shares dividends (in shares)	0		0	8,012	0		0
2023 Series X Private Placement shares dividends							$ 0		0		0		0	0
Net loss — the Company							0		0		(9,794)		0	(9,794)
Net income — non-controlling interest							0		0		0		5	5
Stock-based compensation							$ 0		339		0		0	339
Balance (in shares) at Mar. 31, 2024	3,185,000		1,575,810	264,368	0		6,355,230
Balance at Mar. 31, 2024							$ 30		249,180		(271,697)		575	(21,912)
Balance (in shares) at Dec. 31, 2023	3,185,000		1,575,810	256,356	0		5,529,149
Balance at Dec. 31, 2023							$ 30		247,854		(261,903)		570	(13,449)
Net income — non-controlling interest														76
Balance (in shares) at Sep. 30, 2024	1,835,000		1,575,810	281,150	780,569		7,255,277
Balance at Sep. 30, 2024							$ 30		311,012		(300,934)		520	10,628
Balance (in shares) at Mar. 31, 2024	3,185,000		1,575,810	264,368	0		6,355,230
Balance at Mar. 31, 2024							$ 30		249,180		(271,697)		575	(21,912)
2023 Series X Private Placement shares dividends (in shares)	0		0	8,025	0		0
2023 Series X Private Placement shares dividends							$ 0		0		0		0	0
Net loss — the Company							0		0		(19,951)		0	(19,951)
Net income — non-controlling interest							0		0		0		87	87
Stock-based compensation							$ 0		239		0		0	239
Exchange of MSLP Loan for Series Y Private Placement shares (in shares)	0		0	0	576,986		0
Exchange of MSLP Loan for Series Y Private Placement shares							$ 0		45,901		0		0	45,901
Conversion of 2022 Private Placement shares (in shares)	(1,350,000)
Conversion of 2022 Private Placement shares (in shares)			0	0	0		900,047
Conversion of 2022 Private Placement shares									0		0		0	0
Balance (in shares) at Jun. 30, 2024	1,835,000		1,575,810	272,393	576,986		7,255,277
Balance at Jun. 30, 2024							$ 30		295,320		(291,648)		662	4,364
2023 Series X Private Placement shares dividends (in shares)	0		0	8,757	0		0
2023 Series X Private Placement shares dividends							$ 0		0		0		0	0
Net loss — the Company							0		0		(9,286)		0	(9,286)
Net income — non-controlling interest							0		0		0		(16)	(16)
Stock-based compensation							$ 0		239		0		0	239
Exchange of MSLP Loan for Series Y Private Placement shares (in shares)	0		0	0	203,583		0
Exchange of MSLP Loan for Series Y Private Placement shares							$ 0		15,453		0		0	15,453
Dividends from subsidiaries							$ 0		0		0		(126)	(126)
Balance (in shares) at Sep. 30, 2024	1,835,000		1,575,810	281,150	780,569		7,255,277
Balance at Sep. 30, 2024							$ 30		$ 311,012		$ (300,934)		$ 520	$ 10,628
[1]Amounts associated with Private Placement and Preferred shares round to $nil.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (9,302)		$ (8,956)	$ (38,955)	$ (25,900)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization				2,924	3,042
Stock-based compensation				817	1,214
Provision for expected credit losses	425	$ 171		869	1,263	$ 1,350
Provision for inventory obsolescence				950	760
Finance expenses and accretion				4,150	1,310
Deferred tax expense (recovery)				(275)	14
Loss on sale of subsidiary				0	77
Loss on extinguishment of debt	454		0	11,355	0
Loss (gain) on disposal of property and equipment				2	(1)
Changes in operating assets and liabilities:
Accounts receivable short-term and long-term				9,914	11,146
Inventories				3,218	(246)
Prepaid expenses				296	527
Advances to suppliers				1,096	128
Other current assets				712	1,268
Operating right-of-use assets, net				926	1,215
Other long-term assets				(281)	(380)
Trade payables				(1,607)	(913)
Accrued expenses and other current liabilities				(1,583)	(4,483)
Current operating lease liabilities				(183)	(292)
Severance pay funds				147	148
Unearned interest income				(718)	(960)
Long-term operating lease liabilities				(829)	(917)
Other long-term liabilities				(204)	(105)
Net cash used in operating activities				(7,259)	(12,085)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment				(43)	(89)
Net cash used in investing activities				(43)	(89)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock				10	1,109
2023 Multi-Tranche Private Placement, net of costs of $491				0	4,509
2024 Registered Direct Offering shares and warrants, net of costs of $222				976	0
Dividends from subsidiaries paid to non-controlling interest				(126)	(87)
Proceeds from Short-Term Bridge Financing from Madryn, net of costs of $310				3,928	0
2024 Convertible Notes issued to EW, net of costs of $393				1,607	0
Net cash provided by financing activities				6,395	5,531
NET DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH				(907)	(6,643)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of period		$ 5,396		5,396	11,569	11,569
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH — End of period	$ 4,489		$ 4,926	4,489	4,926	$ 5,396
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for income taxes				98	90
Cash paid for interest				$ 1,633	$ 3,356

Note 1 - Nature of Operations

Note 1 - Nature of Operations	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Nature of Operations [Text Block]	1. Venus Concept Inc. is a global medical technology company that develops, commercializes, and sells minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The Company's systems have been designed on cost-effective, proprietary and flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family and general practitioners and aesthetic medical spas. The Company was incorporated in the state of Delaware on November 22, 2002. Review of Strategic Alternatives On January 24, 2024, may one There can be no not not Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the foreseeable future, and, as such, the unaudited condensed consolidated financial statements do not The Company has had recurring net operating losses and negative cash flows from operations. As of September 30, 2024 December 31, 2023 a September 30, 2024 December 31, 2023 12 In order to continue its operations, the Company must achieve profitable operations and/or obtain additional equity or debt financing. Until the Company achieves profitability, management plans to fund its operations and capital expenditures with cash on hand, borrowings, and issuance of capital stock. Until the Company generates revenue at a level to support its cost structure, the Company expects to continue to incur substantial operating losses and net cash outflows from operating activities. Given the economic uncertainty in U.S. and international markets, the Company cannot anticipate the extent to which the current financial market conditions will continue to adversely impact the Company’s business and the Company may no may not The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the foreseeable future, and, as such, the unaudited condensed consolidated financial statements do not

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and with the instructions to Form 10 10 X. not 10 December 31, 2023 April 1, 2024. nine September 30, 2024 not may December 31, 2024. 8 10 The preparation of these condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company as of September 30, 2024 not Amounts reported in thousands within this report are computed based on the amounts in U.S. dollars. As a result, the sum of the components reported in thousands may not may not Accounting Policies The accounting policies the Company follows are set forth in the Company’s audited consolidated financial statements for fiscal year 2023 8 10 no Recently Adopted Accounting Standards In August 2020, No. 2020 06 2020 06” 470 20 815 40 2020 06 2020 06 January 1, 2024, No. 2020 06 January 1, 2024, 2020 06 not Recently Issued Accounting Standards Not In October 2023, No. 2023 06 2023 06" not June 30, 2027. In November 2023, No. 2023 07 2023 07" 280 December 15, 2023, December 15, 2024. In December 2023, No. 2023 09 2023 09" 740 December 15, 2024

Note 3 - Net Loss Per Share

Note 3 - Net Loss Per Share	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Earnings Per Share [Text Block]	3. Net Loss Per Share Basic net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding during the period, without consideration for common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, common stock warrants and stock options are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive. The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Numerator: Net loss $ (9,302 ) $ (8,956 ) $ (38,955 ) $ (25,900 ) Net loss allocated to stockholders of the Company $ (9,286 ) $ (9,068 ) $ (39,031 ) $ (26,134 ) Denominator: Weighted-average shares of common stock outstanding used in computing net loss per share, basic 7,255 5,527 6,547 5,413 Weighted-average shares of common stock outstanding used in computing net loss per share, diluted 7,255 5,527 6,547 5,413 Net loss per share: Basic $ (1.28 ) $ (1.64 ) $ (5.96 ) $ (4.83 ) Diluted $ (1.28 ) $ (1.64 ) $ (5.96 ) $ (4.83 ) Due to the net loss, all the outstanding shares of common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders for the quarters ended September 30, 2024 2023 September 30, 2024 September 30, 2023 Options to purchase common stock 993,327 1,000,079 Preferred stock 86,294,014 4,985,608 Shares reserved for convertible notes 2,853,024 570,088 Warrants for common stock 1,936,920 1,061,930 Total potential dilutive shares 92,077,285 7,617,705

Note 4 - Fair Value Measurement

Note 4 - Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Fair Value Disclosures [Text Block]	4. Financial assets and financial liabilities are initially recognized at fair value when the Company becomes a party to the contractual provisions of the financial instrument. Subsequently, all financial instruments are measured at amortized cost using the effective interest method. The financial instruments of the Company consist of cash and cash equivalents, restricted cash, accounts receivable, long-term receivables, lines of credit, trade payables, accrued expenses and other current liabilities, note payable, other long-term liabilities and long-term debt. In view of their nature, the fair value of these financial instruments approximates their carrying amounts. The Company measures the fair value of its financial assets and financial liabilities using the fair value hierarchy. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The accounting guidance establishes a three Level 1 Level 2 1 not Level 3 no Guaranteed investment certificates are classified within Level 2 The Company's convertible note (see Note 13 not 3 3. The following tables set forth the fair value of the Company’s Level 1, 2 3 no 1, 2 3 Fair Value Measurements as of September 30, 2024 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates $ — $ 30 $ — $ 30 Total assets $ — $ 30 $ — $ 30 Liabilities Derivative Liability — — 327 327 Total liabilities $ — $ — $ 327 $ 327 Fair Value Measurements as of December 31, 2023 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates $ — $ 62 $ — $ 62 Total assets $ — $ 62 $ — $ 62

Note 5 - Accounts Receivable

Note 5 - Accounts Receivable	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Trade and Financing Receivables [Text Block]	5. The Company’s products may January 2024, A financing receivable is a contractual right to receive money, on demand or on fixed or determinable dates, that is recognized as an asset on the Company's unaudited condensed consolidated balance sheets. The Company's financing receivables, consisting of sales-type leases, totaled $22,223 and $32,393 as of September 30, 2024 December 31, 2023 The Company performed an assessment of the allowance for expected credit losses as of September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 A summary of the Company’s accounts receivables is presented below: September 30, December 31, 2024 2023 Gross accounts receivable $ 34,100 $ 47,884 Unearned income (1,421 ) (2,139 ) Allowance for expected credit losses (4,133 ) (7,415 ) $ 28,546 $ 38,330 Reported as: Current trade receivables $ 21,102 $ 29,151 Current unearned interest income (1,027 ) (1,468 ) Long-term trade receivables 8,865 11,318 Long-term unearned interest income (394 ) (671 ) $ 28,546 $ 38,330 Current Venus Prime and subscription agreements are reported as part of accounts receivable. The following are the contractual commitments, net of allowance for expected credit losses, to be received by the Company over the next 5 September 30, Total 2024 2025 2026 2027 2028 Current financing receivables, net of allowance of $ 4,133 $ 13,359 $ 13,359 $ — $ — $ — Long-term financing receivables, net of allowance of $ 0 8,865 — 6,075 2,751 39 — $ 22,224 $ 13,359 $ 6,075 $ 2,751 $ 39 $ — Accounts receivable from our Venus Prime program bear interest commensurate with the customer's credit risk. Accounts receivable from our legacy subscription model do not not may The allowance for expected credit losses consisted of the following activity: Balance at January 1, 2023 $ 13,619 Write-offs (7,554 ) Provision 1,350 Balance at December 31, 2023 $ 7,415 Write-offs (2,269 ) Provision 171 Balance at March 31, 2024 $ 5,317 Write-offs (1,429 ) Provision 273 Balance at June 30, 2024 $ 4,161 Write-offs (453 ) Provision 425 Balance at September 30, 2024 $ 4,133

Note 6 - Select Balance Sheet a

Note 6 - Select Balance Sheet and Statement of Operations Information	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Balance Sheet and Income Statement Disclosures [Text Block]	6. Inventory Inventory consists of the following: September 30, December 31, 2024 2023 Raw materials $ 1,750 $ 1,949 Work-in-progress 1,567 2,048 Finished goods 15,587 19,075 Total inventory $ 18,904 $ 23,072 Additions to inventory are primarily comprised of newly produced units and applicators, refurbishment cost from demonstration units and used equipment which were reacquired during the period from upgraded sale s. The Company expens in cost of goods sold in the three nine September 30, 2024, The Company expensed $5,109 and $17,009 in cost of goods sold in the three nine September 30, 2023, The Company provides for excess and obsolete inventories when conditions indicate that the inventory cost is not September 30, 2024 December 31, 2023 Property and Equipment, Net Property and equipment, net consist of the following: Useful Lives September 30, December 31, (in years) 2024 2023 Lab equipment tooling and molds 4 – 10 $ 4,356 $ 4,356 Office furniture and equipment 6 – 10 1,227 1,223 Leasehold improvements up to 10 857 854 Computers and software 3 956 919 Vehicles 5 – 7 51 37 Demo units 5 214 214 Total property and equipment 7,661 7,603 Less: Accumulated depreciation (6,623 ) (6,281 ) Total property and equipment, net $ 1,038 $ 1,322 Depreciation expense amounted to $98 and $134 for the three September 30, 2024 2023 nine September 30, 2024 2023 Other Current Assets September 30, December 31, 2024 2023 Government remittances (1) $ 642 $ 1,336 Consideration receivable from subsidiaries sale 55 85 Sundry assets and miscellaneous 516 504 Total other current assets $ 1,213 $ 1,925 ( 1 Accrued Expenses and Other Current Liabilities September 30, December 31, 2024 2023 Payroll and related expense $ 1,330 $ 2,260 Accrued expenses 4,620 3,924 Commission accrual 1,851 2,385 Sales and consumption taxes 2,873 3,868 Total accrued expenses and other current liabilities $ 10,674 $ 12,437 Warranty Accrual The following table provides the details of the change in the Company’s warranty accrual: September 30, December 31, 2024 2023 Balance as of the beginning of the period $ 1,363 $ 1,482 Warranties issued during the period 299 933 Warranty costs incurred during the period (321 ) (1,052 ) Balance at the end of the period $ 1,341 $ 1,363 Current 1,072 1,029 Long-term 269 334 Total $ 1,341 $ 1,363 Finance Expenses The following table provides the details of the Company’s finance expenses: Three Months Ended September 30, Nine Months Ended September 30, 2024 2024 2023 Interest expense $ 1,487 $ 1,539 $ 5,394 $ 4,469 Change in fair value of derivative liability — — (618 ) — Accretion on long-term debt and amortization of fees 178 66 1,009 197 Total finance expenses $ 1,665 $ 1,605 $ 5,785 $ 4,666

Note 7 - Leases

Note 7 - Leases	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	7. LEASES The following presents the various components of lease costs. Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Operating lease cost $ 355 $ 491 $ 1,110 $ 1,494 Total lease cost $ 355 $ 491 $ 1,110 $ 1,494 The following table presents supplemental information relating to the cash flows arising from lease transactions. Cash payments related to short-term leases are not Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Operating cash outflows from operating leases $ 355 $ 491 $ 1,110 $ 1,494 The following table presents the weighted-average lease term and discount rate for operating leases. At September 30, 2024 2023 Operating leases Weighted-average remaining lease term 1.69 yrs. 3.12 yrs. Weighted-average discount rate 4.00 % 4.00 % The following table presents a maturity analysis of expected undiscounted cash flows for operating leases on an annual basis for the next five Years ending December 31, Operating leases 2024 $ 350 2025 1,306 2026 1,109 2027 595 2028 204 Thereafter 340 Imputed Interest (1) (164 ) Total $ 3,740 ( 1

Note 8 - Intangible Assets

Note 8 - Intangible Assets	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Goodwill and Intangible Assets Disclosure [Text Block]	8. Intangible assets net of accumulated amortization were as follows: At September 30, 2024 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (592 ) $ 808 Brand 2,500 (1,526 ) 974 Technology 16,900 (13,845 ) 3,055 Supplier agreement 3,000 (1,991 ) 1,009 Total intangible assets $ 23,800 $ (17,954 ) $ 5,846 At December 31, 2023 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (522 ) $ 878 Brand 2,500 (1,330 ) 1,170 Technology 16,900 (11,735 ) 5,165 Supplier agreement 3,000 (1,767 ) 1,233 Total intangible assets $ 23,800 $ (15,354 ) $ 8,446 For the three September 30, 2024 2023 , respectively nine September 30, 2024 2023 , respectively Estimated remaining amortization expense for the next five Years ending December 31, 2024 $ 873 2025 3,003 2026 657 2027 657 2028 244 Thereafter 412 Total $ 5,846

Note 9 - Commitments and Contin

Note 9 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	9. Commitments As of September 30, 2024 September 30, 2024 270 Aggregate future service and purchase commitments with manufacturers as of September 30, 2024 Years ending December 31, Purchase and Service Commitments 2024 $ 11,719 2025 and Thereafter — Total $ 11,719

Note 10 - Main Street Term Loan

Note 10 - Main Street Term Loan	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	10. On December 8, 2020, 13 3 December 9, 2020, five 30 December 8, 2023 December 8, 2024, fifteen December 8, 2025. may On October 4, 2023, December 31, 2023 December 31, 2024 one three one three one On January 18, 2024, 2023 January 31, 2024, February 28, 2024 March 31, 2024 April 30, 2024. On April 23, 2024, May 24, 2024, May 2024 June 2024 June 7, 2024. On May 24, 2024, "2024 five 2024 100. On June 7, 2024, June 21, 2024, July 2024 July 8, 2024. On July 8, 2024, August 2, 2024, June 30, 2024 On July 29, 2024, August 30, 2024, August 8, 2024 On August 30, 2024, September 30, 2024, September 8, 2024 On September 26, 2024, 2024 September 26, 2024 October 2024 As of September 30, 2024 December 31, 2023 The scheduled payments, inclusive of principal and estimated interest, on the outstanding borrowings as of September 30, 2024 As of September 30, 2024 2024 $ 238 2025 2,679 Total $ 2,917

Note 11 - Madryn Debt and Conve

Note 11 - Madryn Debt and Convertible Notes	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	10. On December 8, 2020, 13 3 December 9, 2020, five 30 December 8, 2023 December 8, 2024, fifteen December 8, 2025. may On October 4, 2023, December 31, 2023 December 31, 2024 one three one three one On January 18, 2024, 2023 January 31, 2024, February 28, 2024 March 31, 2024 April 30, 2024. On April 23, 2024, May 24, 2024, May 2024 June 2024 June 7, 2024. On May 24, 2024, "2024 five 2024 100. On June 7, 2024, June 21, 2024, July 2024 July 8, 2024. On July 8, 2024, August 2, 2024, June 30, 2024 On July 29, 2024, August 30, 2024, August 8, 2024 On August 30, 2024, September 30, 2024, September 8, 2024 On September 26, 2024, 2024 September 26, 2024 October 2024 As of September 30, 2024 December 31, 2023 The scheduled payments, inclusive of principal and estimated interest, on the outstanding borrowings as of September 30, 2024 As of September 30, 2024 2024 $ 238 2025 2,679 Total $ 2,917
Madryn Long Term Debt and Convertible Notes [Member]
Notes to Financial Statements
Debt Disclosure [Text Block]	11. Convertible Notes On October 11, 2016, On December 9, 2020, 10 December 8, 2020, December 9, 2020 ( December 9, 2020 On October 4, 2023, "2023 2023 X X X 5635 3 four December 31, 2023. December 9, 2025 On May 24, 2024, 2024 10 As of September 30, 2024, 2024 In connection with the New Convertible Notes and Notes, the Company recognized interest expense of $903 and $557 during the three September 30, 2024 2023, nine September 30, 2024 2023, 815 10 15 not 815, two September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 The scheduled payments, inclusive of principal and interest, on the outstanding borrowings of the Notes and New Convertible Notes as of September 30, 2024 As of September 30, 2024 2024 $ — 2025 30,917 Total $ 30,917 For the three nine September 30, 2024 not Bridge Financing On April 23, 2024, “2024 “2024 2024 one May 26, 2024. 2024 Borrowings under the Loan and Security Agreement will bear interest at a rate per annum equal to 12%, due at maturity. The Loan and Security Agreement also provides that all present and future indebtedness and the obligations of the Bridge Borrower to Madryn Health Partners, LP shall be secured by a priority security interest in all real and personal property collateral of the Bridge Financing Loan Parties. The Loan and Security Agreement contains customary representations, warranties and affirmative and negative covenants. In addition, the Loan and Security Agreement contains customary events of default that entitle Madryn Health Partners, LP to cause the Bridge Borrower’s indebtedness under the Loan and Security Agreement to become immediately due and payable, and to exercise remedies against the Bridge Financing Loan Parties and the collateral securing the Bridge Financing. Under the Loan and Security Agreement, an event of default will occur if, among other things, any of the Bridge Financing Loan Parties fails to make payments under the Loan and Security Agreement, any of the Bridge Financing Loan Parties breaches any of the covenants under the Loan and Security Agreement, a Change of Control (as defined in the Loan and Security Agreement) occurs, any of the Bridge Financing Loan Parties, or its assets, become subject to certain legal proceedings, such as bankruptcy proceedings. Upon the occurrence and for the duration of an event of default, a default interest rate equal to 15.0% per annum will apply to all obligations owed under the Loan and Security Agreement. On May 24, 2024, 2024 10 May 26, 2024 June 7, 2024. June 7, 2024, June 7, 2024 June 21, 2024. June 21, 2024, 2024 June 21, 2024 July 8, 2024. On July 8, 2024, April 23, 2024, 2024 July 8, 2024 August 2, 2024. On July 26, 2024, 2024 “July July July 26, 2024. On July 29, 2024, ten two $2,762 August 2, 2024 August 30, 2024. On August 30, 2024 August 30, 2024 September 30, 2024. On September 11, 2024, 2024 September 11, 2024. On September 26, 2024, September 30, 2024 October 31, 2024. The scheduled payments, inclusive of principal and interest of $4.4 million will be paid at maturity. For the three nine September 30, 2024, not

Note 12 - Credit Facility

Note 12 - Credit Facility	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Credit Facility Disclosure [Text Block]	12. CREDIT FACILITY On August 29, 2018, March 20, 2020, December 9, 2020 August 26, 2021 ( August 29, 2018, March 20, 2020, December 9, 2020 August 26, 2021 ( March 20, 2020, December 9, 2020 August 26, 2021, On August 26, 2021, 30 LIBOR December 10, 2021, August 26, 2021, July 24, 2023 August 26, 2021 As of the expiration of the credit facility, the Company was in compliance with all required covenants. An event of default under this agreement prior to expiration in July 2023 10

Note 13 - EW Convertible Notes

Note 13 - EW Convertible Notes	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Convertible Notes [Text Block]	13. EW CONVERTIBLE NOTES On January 18, 2024, “2024 The 2024 90 SOFR March 31, 2024. 2024 December 9, 2025 may 2024 one 2024 2024 not 2024 2024 2024 The 2024 2024 may, 2024 2024 2024 2024 2024 On January 18, 2024, 2024 2024 Pursuant to the EW Security Agreement, during the continuance of an Event of Default under the 2024 2024 may, The EW Security Agreement contains various covenants that limit the Company’s ability to engage in specified types of transactions. Subject to limited exceptions, these covenants include restrictions on the Company’s ability, to incur, create or permit to exist additional indebtedness, or liens, and to make certain changes to its ownership structure, in each case without the Investor’s consent. On January 18, 2024, 2024 October 4, 2023 ( December 8, 2020 2024 2024 first As of September 30, 2024, 2024 In connection with the 2024 three nine September 30, 2024, 2024 815, September 30, 2024 As of September 30, 2024 December 31, 2023, The scheduled payments, inclusive of principal and interest, on the outstanding borrowings as of September 30, 2024 As of September 30, 2024 2024 $ — 2025 2,590 Total $ 2,590 For the three nine September 30, 2024, not

Note 14 - Common Stock Reserved

Note 14 - Common Stock Reserved for Issuance	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Common Stock Reserved For Issuance [Text Block]	14. The Company is required to reserve and keep available out of its authorized but unissued shares of common stock a number of shares sufficient to affect the exercise of all classes of preferred stock, convertible promissory notes, options granted and available for grant under the incentive plans and warrants to purchase common stock. September 30, 2024 December 31, 2023 Outstanding common stock warrants 1,936,920 1,061,930 Outstanding stock options and RSUs 993,327 981,834 Preferred shares 86,294,014 8,889,221 Shares reserved for conversion of future voting preferred share issuance 5,596,273 5,844,213 Shares reserved for future option grants and RSUs 308,878 99,580 Shares reserved for Lincoln Park — 711,180 Shares reserved for Madryn Noteholders 1,300,000 1,300,000 Shares reserved for EW Noteholders 2,100,000 — Total common stock reserved for issuance 98,529,412 18,887,958

Note 15 - Stockholders' Equity

Note 15 - Stockholders' Equity	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Equity [Text Block]	15. Common Stock The Company’s common stock confers upon its holders the following rights: • The right to participate and vote in the Company’s stockholder meetings, whether annual or special. Each share will entitle its holder, when attending and participating in the voting in person or via proxy, to one • The right to a share in the distribution of dividends, whether in cash or in the form of bonus shares, the distribution of assets or any other distribution pro rata to the par value of the shares held by them; and • The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the shares held by them. Reverse Stock Split At the annual and special meeting of the Company’s shareholders held on May 10, 2023, one five 1 one fifteen 1 May 11, 2023, one fifteen 1 May 12, 2023. Equity Purchase Agreement with Lincoln Park On June 16, 2020, may may no no 5635 no may From commencement to expiry on July 1, 2022, 2022, December 31, 2022 July 1, 2022, 2022 2022 On July 12, 2022, “2022 July 1, 2022. 2022 may 2022 “2022 2022 2022 may not 2022 “2022 2022 2022 no 2022 2022 five 2022 2022 2022 2022 may not 2022 2022 2022 December 31, 2023 nine September 30, 2024, 2022 August 1, 2024. The 2022 November 2022, "2022 2022 2022 30 "2022 2022 November 18, 2022. 2022 2022 2022 Voting Preferred Stock issued in November 2022 As noted above, in November 2022, 2022 November 17, 2022. • Voting Rights. • Liquidation. • Conversion one 2022 30 30 two • Dividends. • Redemption not • Maturity. The 2023 In May 2023, "2023 "2023 may 2023 "2023 December 31, 2025, 2023 May 15, 2023, 2023 • Voting Rights. no two not not • Liquidation. • Conversion one 30 30 • Dividends. • Redemption not • Maturity. On July 6, 2023, 2023 2023 5635 2023 2023 On July 12, 2023, 2023 second 2023 2023 On September 8, 2023, 2023 third 2023 2023 On October 20, 2023, 2023 fourth 2023 2023 Series X On October 4, 2023, X X X X one X X • Voting Rights. X 1 X • Liquidation. X X • Conversion X 1 X • Dividends. X X X • Redemption X not • Maturity. X December 31, 2026. Series Y Convertible Preferred Stock On May 24, 2024, 1 not no September 26, 2024 600,000 • Voting Rights. not • Liquidation. X • Conversion 1 • Dividends. • Redemption not • Maturity. Registered Direct Offering On February 22, 2024, “2024 2024 “2024 The Shares were offered at-the-market under Nasdaq rules and pursuant to the Company’s shelf registration statement on Form S- 3 October 15, 2021 October 25, 2021. The 2024 2024 not 4 2 2024 five may 2024 2024 2024 A holder is not 2024 13 16 2024 may 61 may not On February 27, 2024, Under the SPA, no March 8, 2024, 3 not 3 2024 45 75 no 2024 2024 The SPA contains customary representations, warranties and covenants by the Company, among other customary provisions. H.C. Wainwright & Co., LLC (“HCW”) acted as the Company’s placement agent in connection with Offering. The Company paid HCW consideration consisting of (i) a cash fee equal to 7.0% of the aggregate gross proceeds in the Offering, (ii) a management fee equal to 1.0% of the aggregate gross proceeds in the Offering, (iii) reimbursement of certain expenses and (iv) warrants to acquire up to an aggregate of 57,242 shares of common stock (the “Placement Agent Warrants”). The Placement Agent Warrants are similar to the 2024 2010 In November 2010, “2010 2010 seven ten November 2017 2010 not September 30, 2024 2010 December 31, 2023 2019 Incentive Award Plan The 2019 “2019 2017 September 12, 2017 September 14, 2017. 2017 October 4, 2019. Under the 2019 2019 September 30, 2024 2019 December 31, 2023 2019 first 2020 2029 four The Company recognized stock-based compensation for its employees and non-employees in the accompanying unaudited condensed consolidated statements of operations as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Cost of sales $ 9 $ 11 $ 28 $ 37 Selling and marketing 58 81 190 266 General and administrative 148 243 524 794 Research and development 24 29 75 117 Total stock-based compensation $ 239 $ 364 $ 817 $ 1,214 Stock Options The fair value of each option is estimated at the date of grant using the Black-Scholes option pricing formula with the following assumptions: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Expected term (in years) - 6.00 6.00 6.00 Risk-free interest rate - 4.33 % 4.23 % 3.37-4.33 % Expected volatility - 42.29 % 43.06 % 42.94 % Expected dividend rate - 0 % 0 % 0 % Expected Term Volatility not Risk-Free Interest Rate zero Dividend Rate not Fair Value of Common Stock The following table summarizes stock option activity under the Company’s stock option plan: Number of Shares Weighted- Average Exercise Price per Share, $ Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding – January 1, 2024 981,834 $ 19.85 7.58 $ — Options granted 82,000 0.71 - — Options exercised - - - — Options forfeited/cancelled (70,507 ) 33.79 - — Outstanding – September 30, 2024 993,327 17.28 7.34 $ — Exercisable – September 30, 2024 524,739 27.07 6.56 $ — Expected to vest – after September 30, 2024 468,588 $ 6.32 8.22 $ — The following tables summarize information about stock options outstanding and exercisable at September 30, 2024 Options Outstanding Options Exercisable Exercise Price Range Number Weighted average remaining contractual term (years) Weighted average Exercise Price Options exercisable Weighted average remaining contractual term (years) Weighted average Exercise Price $0.7051 - $54.60 952,221 7.52 $13.24 483,810 6.84 $19.99 $63.90 - $119.25 38,947 3.16 97.80 38,770 3.15 97.70 $186.75 - $382.50 1,627 3.99 271.15 1,627 3.99 271.15 $405.00 - $438.75 263 0.71 405.51 263 0.71 405.51 $650.25 - $958.50 269 3.70 727.38 269 3.70 727.38 993,327 7.34 $17.28 524,739 6.56 $27.07 The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those options that had exercise prices lower than the fair value of the Company’s common stock. The total intrinsic value of options exercised were $nil $nil three September 30, 2024 2023, $nil $nil nine September 30, 2024 2023, The weighted-average grant date fair value of options granted was $nil three September 30, 2024 2023, nine September 30, 2024 2023, three September 30, 2024 2023 nine September 30, 2024 2023

Note 16 - Income Taxes

Note 16 - Income Taxes	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Income Tax Disclosure [Text Block]	16. The Company generated a loss and recognize d $31 of tax benefit for the three September 30, 2024 , and $321 of tax benefit for the three September 30, 2023 , respectively. T d $147 of tax expense for the nine September 30, 2024 , and $103 of tax expense for the nine September 30, 2023 , respectively. A reconciliation of income tax (benefit) expense is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Loss before income taxes $ (9,333 ) $ (9,277 ) $ (38,808 ) $ (25,797 ) Theoretical tax expense at the statutory rate ( 21 (1,960 ) (1,961 ) (8,150 ) (5,417 ) Differences in jurisdictional tax rates (437 ) (417 ) (1,807 ) (965 ) Valuation allowance 2,282 2,343 9,604 6,675 Non-deductible expenses 84 89 500 186 Other — (375 ) — (376 ) Total income tax provision (recovery) (31 ) (321 ) 147 103 Net loss $ (9,302 ) $ (8,956 ) $ (38,955 ) $ (25,900 ) Income tax expense is recognized based on the actual loss incurred during the three nine September 30, 2024 2023

Note 17 - Segment and Geographi

Note 17 - Segment and Geographic Information	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	17. Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company's CODM is its Chief Executive Officer. The Company has determined it operates in a single operating segment and has one not Revenue by geographic location, which is based on the product shipped to location, is summarized as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 United States $ 8,548 $ 11,167 $ 27,902 $ 31,665 International 6,459 6,449 21,166 26,557 Total revenue $ 15,007 $ 17,616 $ 49,068 $ 58,222 As of September 30, 2024 were located in the United States and $856 December 31, 2023 Revenue by type is a key indicator for providing management with an understanding of the Company’s financial performance, which is organized into four 1. 2. 3. 4. The following table presents revenue by type: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Lease revenue $ 2,684 $ 4,368 $ 10,732 $ 14,440 System revenue 8,898 9,834 28,020 33,212 Product revenue 2,741 2,487 7,945 8,019 Service revenue 684 927 2,371 2,551 Total revenue $ 15,007 $ 17,616 $ 49,068 $ 58,222

Note 18 - Related Party Transac

Note 18 - Related Party Transactions	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	18. All amounts were recorded at the exchange amount, which is the amount established and agreed to by the related parties. The following are transactions between the Company and parties related through employment. Distribution agreements On January 1, 2018, nine September 30, 2024 2023 $nil June 2023. In 2020, January 1, 2021, nine September 30, 2024 2023 $nil June 2023.

Note 19 - Subsequent Events

Note 19 - Subsequent Events	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	19. Nasdaq Bid-Price Deficiency Extension On April 11, 2024, 32 not $1.00 5550 2 In accordance with Nasdaq Listing Rule 5810 3 180 October 8, 2024 ( not On October 17, 2024, 180 April 7, 2025, ( $1.00 10 10 5810 3 If the Company does not may no Consent Agreement On October 31, 2024, The Consent Agreement granted relief under the MSLP Loan Agreement, such that (i) certain minimum liquidity requirements under the MSLP Loan Agreement are waived through November 30, 2024, November 8, 2024 Eighth Bridge Loan Amendment On October 31, 2024, October 31, 2024 November 30, 2024. Bridge Loan Drawdown As previously disclosed, on April 23, 2024, 2024 On October 30, 2024, 2024 “November November November 1, 2024. November

Insider Trading Arrangements

Insider Trading Arrangements	9 Months Ended
	Sep. 30, 2024
Insider Trading Arr Line Items
Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and with the instructions to Form 10 10 X. not 10 December 31, 2023 April 1, 2024. nine September 30, 2024 not may December 31, 2024. 8 10 The preparation of these condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company as of September 30, 2024 not Amounts reported in thousands within this report are computed based on the amounts in U.S. dollars. As a result, the sum of the components reported in thousands may not may not
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Standards In August 2020, No. 2020 06 2020 06” 470 20 815 40 2020 06 2020 06 January 1, 2024, No. 2020 06 January 1, 2024, 2020 06 not Recently Issued Accounting Standards Not In October 2023, No. 2023 06 2023 06" not June 30, 2027. In November 2023, No. 2023 07 2023 07" 280 December 15, 2023, December 15, 2024. In December 2023, No. 2023 09 2023 09" 740 December 15, 2024

Note 3 - Net Loss Per Share (Ta

Note 3 - Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Numerator: Net loss $ (9,302 ) $ (8,956 ) $ (38,955 ) $ (25,900 ) Net loss allocated to stockholders of the Company $ (9,286 ) $ (9,068 ) $ (39,031 ) $ (26,134 ) Denominator: Weighted-average shares of common stock outstanding used in computing net loss per share, basic 7,255 5,527 6,547 5,413 Weighted-average shares of common stock outstanding used in computing net loss per share, diluted 7,255 5,527 6,547 5,413 Net loss per share: Basic $ (1.28 ) $ (1.64 ) $ (5.96 ) $ (4.83 ) Diluted $ (1.28 ) $ (1.64 ) $ (5.96 ) $ (4.83 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	September 30, 2024 September 30, 2023 Options to purchase common stock 993,327 1,000,079 Preferred stock 86,294,014 4,985,608 Shares reserved for convertible notes 2,853,024 570,088 Warrants for common stock 1,936,920 1,061,930 Total potential dilutive shares 92,077,285 7,617,705

Note 4 - Fair Value Measureme_2

Note 4 - Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Fair Value, by Balance Sheet Grouping [Table Text Block]	Fair Value Measurements as of September 30, 2024 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates $ — $ 30 $ — $ 30 Total assets $ — $ 30 $ — $ 30 Liabilities Derivative Liability — — 327 327 Total liabilities $ — $ — $ 327 $ 327 Fair Value Measurements as of December 31, 2023 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates $ — $ 62 $ — $ 62 Total assets $ — $ 62 $ — $ 62

Note 5 - Accounts Receivable (T

Note 5 - Accounts Receivable (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	September 30, December 31, 2024 2023 Gross accounts receivable $ 34,100 $ 47,884 Unearned income (1,421 ) (2,139 ) Allowance for expected credit losses (4,133 ) (7,415 ) $ 28,546 $ 38,330 Reported as: Current trade receivables $ 21,102 $ 29,151 Current unearned interest income (1,027 ) (1,468 ) Long-term trade receivables 8,865 11,318 Long-term unearned interest income (394 ) (671 ) $ 28,546 $ 38,330
Contractual Commitments, Net of Allowance For Doubtful Accounts To Be Received Maturity [Table Text Block]	September 30, Total 2024 2025 2026 2027 2028 Current financing receivables, net of allowance of $ 4,133 $ 13,359 $ 13,359 $ — $ — $ — Long-term financing receivables, net of allowance of $ 0 8,865 — 6,075 2,751 39 — $ 22,224 $ 13,359 $ 6,075 $ 2,751 $ 39 $ —
Accounts Receivable, Allowance for Credit Loss [Table Text Block]	Balance at January 1, 2023 $ 13,619 Write-offs (7,554 ) Provision 1,350 Balance at December 31, 2023 $ 7,415 Write-offs (2,269 ) Provision 171 Balance at March 31, 2024 $ 5,317 Write-offs (1,429 ) Provision 273 Balance at June 30, 2024 $ 4,161 Write-offs (453 ) Provision 425 Balance at September 30, 2024 $ 4,133

Note 6 - Select Balance Sheet_2

Note 6 - Select Balance Sheet and Statement of Operations Information (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	September 30, December 31, 2024 2023 Raw materials $ 1,750 $ 1,949 Work-in-progress 1,567 2,048 Finished goods 15,587 19,075 Total inventory $ 18,904 $ 23,072
Property, Plant and Equipment [Table Text Block]	Useful Lives September 30, December 31, (in years) 2024 2023 Lab equipment tooling and molds 4 – 10 $ 4,356 $ 4,356 Office furniture and equipment 6 – 10 1,227 1,223 Leasehold improvements up to 10 857 854 Computers and software 3 956 919 Vehicles 5 – 7 51 37 Demo units 5 214 214 Total property and equipment 7,661 7,603 Less: Accumulated depreciation (6,623 ) (6,281 ) Total property and equipment, net $ 1,038 $ 1,322
Schedule of Other Current Assets [Table Text Block]	September 30, December 31, 2024 2023 Government remittances (1) $ 642 $ 1,336 Consideration receivable from subsidiaries sale 55 85 Sundry assets and miscellaneous 516 504 Total other current assets $ 1,213 $ 1,925
Schedule of Accrued Expenses and Other Current Liabilities [Table Text Block]	September 30, December 31, 2024 2023 Payroll and related expense $ 1,330 $ 2,260 Accrued expenses 4,620 3,924 Commission accrual 1,851 2,385 Sales and consumption taxes 2,873 3,868 Total accrued expenses and other current liabilities $ 10,674 $ 12,437
Schedule of Product Warranty Liability [Table Text Block]	September 30, December 31, 2024 2023 Balance as of the beginning of the period $ 1,363 $ 1,482 Warranties issued during the period 299 933 Warranty costs incurred during the period (321 ) (1,052 ) Balance at the end of the period $ 1,341 $ 1,363 Current 1,072 1,029 Long-term 269 334 Total $ 1,341 $ 1,363
Schedule of Finance Expenses [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2024 2024 2023 Interest expense $ 1,487 $ 1,539 $ 5,394 $ 4,469 Change in fair value of derivative liability — — (618 ) — Accretion on long-term debt and amortization of fees 178 66 1,009 197 Total finance expenses $ 1,665 $ 1,605 $ 5,785 $ 4,666

Note 7 - Leases (Tables)

Note 7 - Leases (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Lease, Cost [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Operating lease cost $ 355 $ 491 $ 1,110 $ 1,494 Total lease cost $ 355 $ 491 $ 1,110 $ 1,494 Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Operating cash outflows from operating leases $ 355 $ 491 $ 1,110 $ 1,494 At September 30, 2024 2023 Operating leases Weighted-average remaining lease term 1.69 yrs. 3.12 yrs. Weighted-average discount rate 4.00 % 4.00 %
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]	Years ending December 31, Operating leases 2024 $ 350 2025 1,306 2026 1,109 2027 595 2028 204 Thereafter 340 Imputed Interest (1) (164 ) Total $ 3,740

Note 8 - Intangible Assets (Tab

Note 8 - Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Intangible Assets and Goodwill [Table Text Block]	At September 30, 2024 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (592 ) $ 808 Brand 2,500 (1,526 ) 974 Technology 16,900 (13,845 ) 3,055 Supplier agreement 3,000 (1,991 ) 1,009 Total intangible assets $ 23,800 $ (17,954 ) $ 5,846 At December 31, 2023 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (522 ) $ 878 Brand 2,500 (1,330 ) 1,170 Technology 16,900 (11,735 ) 5,165 Supplier agreement 3,000 (1,767 ) 1,233 Total intangible assets $ 23,800 $ (15,354 ) $ 8,446
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Years ending December 31, 2024 $ 873 2025 3,003 2026 657 2027 657 2028 244 Thereafter 412 Total $ 5,846

Note 9 - Commitments and Cont_2

Note 9 - Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Contractual Obligation, Fiscal Year Maturity [Table Text Block]	Years ending December 31, Purchase and Service Commitments 2024 $ 11,719 2025 and Thereafter — Total $ 11,719

Note 10 - Main Street Term Lo_2

Note 10 - Main Street Term Loan (Tables)	9 Months Ended
	Sep. 30, 2024
MSLP Note [Member]
Notes Tables
Schedule of Maturities of Long-Term Debt [Table Text Block]	As of September 30, 2024 2024 $ 238 2025 2,679 Total $ 2,917

Note 11 - Madryn Debt and Con_2

Note 11 - Madryn Debt and Convertible Notes (Tables)	9 Months Ended
	Sep. 30, 2024
Secured Subordinated Convertible Notes [Member]
Notes Tables
Schedule of Maturities of Long-Term Debt [Table Text Block]	As of September 30, 2024 2024 $ — 2025 30,917 Total $ 30,917

Note 13 - EW Convertible Notes

Note 13 - EW Convertible Notes (Tables)	9 Months Ended
	Sep. 30, 2024
The 2024 Notes [Member]
Notes Tables
Schedule of Maturities of Long-Term Debt [Table Text Block]	As of September 30, 2024 2024 $ — 2025 2,590 Total $ 2,590

Note 14 - Common Stock Reserv_2

Note 14 - Common Stock Reserved for Issuance (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Common Stock Reserved for Issuance [Table Text Block]	September 30, 2024 December 31, 2023 Outstanding common stock warrants 1,936,920 1,061,930 Outstanding stock options and RSUs 993,327 981,834 Preferred shares 86,294,014 8,889,221 Shares reserved for conversion of future voting preferred share issuance 5,596,273 5,844,213 Shares reserved for future option grants and RSUs 308,878 99,580 Shares reserved for Lincoln Park — 711,180 Shares reserved for Madryn Noteholders 1,300,000 1,300,000 Shares reserved for EW Noteholders 2,100,000 — Total common stock reserved for issuance 98,529,412 18,887,958

Note 15 - Stockholders' Equity

Note 15 - Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Cost of sales $ 9 $ 11 $ 28 $ 37 Selling and marketing 58 81 190 266 General and administrative 148 243 524 794 Research and development 24 29 75 117 Total stock-based compensation $ 239 $ 364 $ 817 $ 1,214
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Expected term (in years) - 6.00 6.00 6.00 Risk-free interest rate - 4.33 % 4.23 % 3.37-4.33 % Expected volatility - 42.29 % 43.06 % 42.94 % Expected dividend rate - 0 % 0 % 0 %
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Number of Shares Weighted- Average Exercise Price per Share, $ Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding – January 1, 2024 981,834 $ 19.85 7.58 $ — Options granted 82,000 0.71 - — Options exercised - - - — Options forfeited/cancelled (70,507 ) 33.79 - — Outstanding – September 30, 2024 993,327 17.28 7.34 $ — Exercisable – September 30, 2024 524,739 27.07 6.56 $ — Expected to vest – after September 30, 2024 468,588 $ 6.32 8.22 $ —
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Exercise Price Range Number Weighted average remaining contractual term (years) Weighted average Exercise Price Options exercisable Weighted average remaining contractual term (years) Weighted average Exercise Price $0.7051 - $54.60 952,221 7.52 $13.24 483,810 6.84 $19.99 $63.90 - $119.25 38,947 3.16 97.80 38,770 3.15 97.70 $186.75 - $382.50 1,627 3.99 271.15 1,627 3.99 271.15 $405.00 - $438.75 263 0.71 405.51 263 0.71 405.51 $650.25 - $958.50 269 3.70 727.38 269 3.70 727.38 993,327 7.34 $17.28 524,739 6.56 $27.07

Note 16 - Income Taxes (Tables)

Note 16 - Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Loss before income taxes $ (9,333 ) $ (9,277 ) $ (38,808 ) $ (25,797 ) Theoretical tax expense at the statutory rate ( 21 (1,960 ) (1,961 ) (8,150 ) (5,417 ) Differences in jurisdictional tax rates (437 ) (417 ) (1,807 ) (965 ) Valuation allowance 2,282 2,343 9,604 6,675 Non-deductible expenses 84 89 500 186 Other — (375 ) — (376 ) Total income tax provision (recovery) (31 ) (321 ) 147 103 Net loss $ (9,302 ) $ (8,956 ) $ (38,955 ) $ (25,900 )

Note 17 - Segment and Geograp_2

Note 17 - Segment and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 United States $ 8,548 $ 11,167 $ 27,902 $ 31,665 International 6,459 6,449 21,166 26,557 Total revenue $ 15,007 $ 17,616 $ 49,068 $ 58,222
Revenue from External Customers by Products and Services [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Lease revenue $ 2,684 $ 4,368 $ 10,732 $ 14,440 System revenue 8,898 9,834 28,020 33,212 Product revenue 2,741 2,487 7,945 8,019 Service revenue 684 927 2,371 2,551 Total revenue $ 15,007 $ 17,616 $ 49,068 $ 58,222

Note 1 - Nature of Operations (

Note 1 - Nature of Operations (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Retained Earnings (Accumulated Deficit)	$ (300,934)	$ (261,903)

Note 3 - Net Loss Per Share - C

Note 3 - Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net loss	$ (9,302)	$ (8,956)	$ (38,955)	$ (25,900)
Net loss allocated to stockholders of the Company	$ (9,286)	$ (9,068)	$ (39,031)	$ (26,134)
Weighted-average shares of common stock outstanding used in computing net loss per share, basic (in shares)	7,255	5,527	6,547	5,413
Weighted-average shares of common stock outstanding used in computing net loss per share, diluted (in shares)	7,255	5,527	6,547	5,413
Basic (in dollars per share)	$ (1.28)	$ (1.64)	$ (5.96)	$ (4.83)
Diluted (in dollars per share)	$ (1.28)	$ (1.64)	$ (5.96)	$ (4.83)

Note 3 - Net Loss Per Share - A

Note 3 - Net Loss Per Share - Antidilutive Securities (Details) - shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Total potential dilutive shares (in shares)	92,077,285	7,617,705
Share-Based Payment Arrangement, Option [Member]
Total potential dilutive shares (in shares)	993,327	1,000,079
Performance Shares [Member]
Total potential dilutive shares (in shares)	86,294,014	4,985,608
Shares Reserved for Convertible Notes [Member]
Total potential dilutive shares (in shares)	2,853,024	570,088
Warrant [Member]
Total potential dilutive shares (in shares)	1,936,920	1,061,930

Note 4 - Fair Value Measureme_3

Note 4 - Fair Value Measurements - Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Assets, fair value	$ 30	$ 62
Derivative Liability	327
Total liabilities	327
Guaranteed Investment Certificates [Member]
Assets, fair value	30	62
Fair Value, Inputs, Level 1 [Member]
Assets, fair value	0	0
Derivative Liability	0
Total liabilities	0
Fair Value, Inputs, Level 1 [Member] | Guaranteed Investment Certificates [Member]
Assets, fair value	0	0
Fair Value, Inputs, Level 2 [Member]
Assets, fair value	30	62
Derivative Liability	0
Total liabilities	0
Fair Value, Inputs, Level 2 [Member] | Guaranteed Investment Certificates [Member]
Assets, fair value	30	62
Fair Value, Inputs, Level 3 [Member]
Assets, fair value	0	0
Derivative Liability	327
Total liabilities	327
Fair Value, Inputs, Level 3 [Member] | Guaranteed Investment Certificates [Member]
Assets, fair value	$ 0	$ 0

Note 5 - Accounts Receivable (D

Note 5 - Accounts Receivable (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Lessor, Sales-type Lease, Term of Contract (Month)	36 months
Sales-type and Direct Financing Leases, Lease Receivable	$ 22,223			$ 32,393
Accounts Receivable, Allowance for Credit Loss	$ 4,133	$ 4,161	$ 5,317	$ 7,415	$ 13,619

Note 5 - Accounts Receivable -

Note 5 - Accounts Receivable - Summary of Accounts Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Gross accounts receivable	$ 34,100			$ 47,884
Unearned income	(1,421)			(2,139)
Allowance for expected credit losses	(4,133)	$ (4,161)	$ (5,317)	(7,415)	$ (13,619)
Accounts Receivable, after Allowance for Credit Loss	28,546			38,330
Current trade receivables	21,102			29,151
Current unearned interest income	(1,027)			(1,468)
Long-term trade receivables	8,865			11,318
Long-term unearned interest income	$ (394)			$ (671)

Note 5 - Accounts Receivable _2

Note 5 - Accounts Receivable - Schedule of Contractual Commitments, Net of Allowance for Doubtful Accounts (Details) $ in Thousands	Sep. 30, 2024 USD ($)
Financing receivables, net	$ 22,224
2024, financing receivables, net	13,359
2025, financing receivables, net	6,075
2026, financing receivables, net	2,751
2027, financing receivables, net	39
2028, financing receivables, net	0
Current Financing Receivables, Net Of Allowance [Member]
Financing receivables, net	13,359
2024, financing receivables, net	13,359
2025, financing receivables, net
2026, financing receivables, net	0
2027, financing receivables, net	0
2028, financing receivables, net	0
Noncurrent Financing Receivables, Net Of Allowance [Member]
Financing receivables, net	8,865
2024, financing receivables, net	0
2025, financing receivables, net	6,075
2026, financing receivables, net	2,751
2027, financing receivables, net	39
2028, financing receivables, net	$ 0

Note 5 - Accounts Receivable _3

Note 5 - Accounts Receivable - Schedule of Contractual Commitments, Net of Allowance for Doubtful Accounts (Details) (Parentheticals) $ in Thousands	Sep. 30, 2024 USD ($)
Current Financing Receivables, Net Of Allowance [Member]
Allowance, current financing receivables, net	$ 4,133
Noncurrent Financing Receivables, Net Of Allowance [Member]
Allowance, noncurrent financing receivables, net	$ 0

Note 5 - Accounts Receivable _4

Note 5 - Accounts Receivable - Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Balance	$ 4,161	$ 5,317	$ 7,415	$ 7,415	$ 13,619	$ 13,619
Write-offs	(453)	(1,429)	(2,269)			(7,554)
Provision	425	273	171	869	$ 1,263	1,350
Balance	$ 4,133	$ 4,161	$ 5,317	$ 4,133		$ 7,415

Note 6 - Select Balance Sheet_3

Note 6 - Select Balance Sheet and Statement of Operations Information (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cost, Direct Material	$ 4,637	$ 5,109	$ 13,839	$ 17,009
Inventory Valuation Reserves	2,775		2,775		$ 2,733
Depreciation	$ 98	$ 134	$ 323	$ 444

Note 6 - Select Balance Sheet_4

Note 6 - Select Balance Sheet and Statement of Operations Information - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Raw materials	$ 1,750	$ 1,949
Work-in-progress	1,567	2,048
Finished goods	15,587	19,075
Total inventory	$ 18,904	$ 23,072

Note 6 - Select Balance Sheet_5

Note 6 - Select Balance Sheet and Statement of Operations Information - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Lab equipment tooling and molds	$ 4,356	$ 4,356
Office furniture and equipment	1,227	1,223
Leasehold improvements	857	854
Computers and software	956	919
Vehicles	51	37
Demo units	214	214
Total property and equipment	7,661	7,603
Less: Accumulated depreciation	(6,623)	(6,281)
Total property and equipment, net	$ 1,038	$ 1,322
Tools, Dies and Molds [Member] | Minimum [Member]
Property and equipment, Useful lives (Year)	4 years
Tools, Dies and Molds [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	10 years
Office Equipment [Member] | Minimum [Member]
Property and equipment, Useful lives (Year)	6 years
Office Equipment [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	10 years
Leasehold Improvements [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	10 years
Computer Equipment [Member]
Property and equipment, Useful lives (Year)	3 years
Vehicles [Member] | Minimum [Member]
Property and equipment, Useful lives (Year)	5 years
Vehicles [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	7 years
Demo Units [Member]
Property and equipment, Useful lives (Year)	5 years

Note 6 - Select Balance Sheet_6

Note 6 - Select Balance Sheet and Statement of Operations Information - Other Current Assets (Details) - USD ($) $ in Thousands		Sep. 30, 2024	Dec. 31, 2023
Government remittances (1)	[1]	$ 642	$ 1,336
Consideration receivable from subsidiaries sale		55	85
Sundry assets and miscellaneous		516	504
Total other current assets		$ 1,213	$ 1,925
[1]Government remittances are receivables from the local tax authorities for refunds of sales taxes and income taxes.

Note 6 - Select Balance Sheet_7

Note 6 - Select Balance Sheet and Statement of Operations Information - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Payroll and related expense	$ 1,330	$ 2,260
Accrued expenses	4,620	3,924
Commission accrual	1,851	2,385
Sales and consumption taxes	2,873	3,868
Total accrued expenses and other current liabilities	$ 10,674	$ 12,437

Note 6 - Select Balance Sheet_8

Note 6 - Select Balance Sheet and Statement of Operations Information - Warranty Accrual (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Balance as of the beginning of the period	$ 1,363	$ 1,482
Warranties issued during the period	299	933
Warranty costs incurred during the period	(321)	(1,052)
Balance at the end of the period	1,341	1,363
Current	1,072	1,029
Long-term	269	334
Total	$ 1,341	$ 1,363

Note 6 - Select Balance Sheet_9

Note 6 - Select Balance Sheet and Statement of Operations Information - Finance Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Interest expense	$ 1,487	$ 1,539	$ 5,394	$ 4,469
Change in fair value of derivative liability	0	0	(618)	0
Accretion on long-term debt and amortization of fees	178	66	1,009	197
Total finance expenses	$ 1,665	$ 1,605	$ 5,785	$ 4,666

Note 7 - Leases - Lease Cost (D

Note 7 - Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Operating lease cost	$ 355	$ 491	$ 1,110	$ 1,494
Total lease cost	355	491	1,110	1,494
Operating cash outflows from operating leases	$ 355	$ 491	$ 1,110	$ 1,494
Weighted-average remaining lease term (Year)	1 year 8 months 8 days		1 year 8 months 8 days		3 years 1 month 13 days
Weighted-average discount rate	4%		4%		4%

Note 7 - Leases - Operating Lea

Note 7 - Leases - Operating Lease Maturity (Details) $ in Thousands	Sep. 30, 2024 USD ($)
2024	$ 350
2025	1,306
2026	1,109
2027	595
2028	204
Thereafter	340
Imputed Interest (1)	(164)	[1]
Total	$ 3,740
[1]Imputed interest represents the difference between undiscounted cash flows and cash flows.

Note 8 - Intangible Assets (Det

Note 8 - Intangible Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Amortization of Intangible Assets	$ 873	$ 875	$ 2,600	$ 2,597

Note 8 - Intangible Assets - Sc

Note 8 - Intangible Assets - Schedule of Intangible Assets Net of Accumulated Amortization and Goodwill (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Gross Amount	$ 23,800	$ 23,800
Accumulated amortization	(17,954)	(15,354)
Net Amount	5,846	8,446
Customer Relationships [Member]
Gross Amount	1,400	1,400
Accumulated amortization	(592)	(522)
Net Amount	808	878
Brand [Member]
Gross Amount	2,500	2,500
Accumulated amortization	(1,526)	(1,330)
Net Amount	974	1,170
Technology [Member]
Gross Amount	16,900	16,900
Accumulated amortization	(13,845)	(11,735)
Net Amount	3,055	5,165
Supplier Agreement [Member]
Gross Amount	3,000	3,000
Accumulated amortization	(1,991)	(1,767)
Net Amount	$ 1,009	$ 1,233

Note 8 - Intangible Assets - Es

Note 8 - Intangible Assets - Estimated Amortization (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
2024	$ 873
2025	3,003
2026	657
2027	657
2028	244
Thereafter	412
Total	$ 5,846	$ 8,446

Note 9 - Commitments and Cont_3

Note 9 - Commitments and Contingencies (Details Textual) $ in Thousands	Sep. 30, 2024 USD ($)
Purchase Obligation	$ 11,719
Contract Manufacturers [Member]
Purchase Obligation	11,700
Open Purchase Order [Member]
Purchase Obligation	$ 2,300

Note 9 - Commitments and Cont_4

Note 9 - Commitments and Contingencies - Contractual Obligation Maturity (Details) $ in Thousands	Sep. 30, 2024 USD ($)
2024	$ 11,719
2025 and Thereafter	0
Total	$ 11,719

Note 10 - Main Street Term Lo_3

Note 10 - Main Street Term Loan (Details Textual) - USD ($) $ / shares in Units, $ in Thousands					3 Months Ended		9 Months Ended
	Sep. 26, 2024	May 24, 2024	Oct. 04, 2023	Dec. 08, 2020	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Gain (Loss) on Extinguishment of Debt					$ (454)	$ 0	$ (11,355)	$ 0
Conversion of MSLP Note [Member]
Debt Conversion, Original Debt, Amount		$ 52,142
Gain (Loss) on Extinguishment of Debt		(10,900)
Conversion of Debt into New Note [Member]
Debt Conversion, Converted Instrument, Amount		$ 17,142
Conversion of Debt Into Series Y Convertible Preferred Stock [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares)		576,986
Preferred Stock, Convertible, Conversion Price (in dollars per share)		$ 60.66
Second 2024 Exchange Agreement [Member]
Debt Conversion, Original Debt, Amount	$ 17,662
Debt Conversion, Converted Instrument, Amount	$ 2,662
Debt Conversion, Converted Instrument, Shares Issued (in shares)	203,583
Gain (Loss) on Extinguishment of Debt	$ 500
MSLP Note [Member]
Debt Instrument, Face Amount				$ 50,000
Debt Instrument, Term (Year)				5 years
MSLP Note [Member] | Debt Instrument, Redemption, Period One [Member]
Debt Instrument, Percentage of Outstanding Principal to be Paid with Accrued Unpaid Interest				15%
MSLP Note [Member] | Debt Instrument, Redemption, Period Two [Member]
Debt Instrument, Percentage of Outstanding Principal to be Paid with Accrued Unpaid Interest			7.50%	15%
MSLP Note [Member] | London Interbank Offered Rate [Member]
Debt Instrument, Basis Spread on Variable Rate				3%
MSLP Note [Member] | Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument, Basis Spread on Variable Rate			3.25%

Note 10 - Main Street Term Lo_4

Note 10 - Main Street Term Loan - Schedule Payments on Outstanding Borrowings (Details) - MSLP Note [Member] $ in Thousands	Sep. 30, 2024 USD ($)
2024	$ 238
2025	2,679
Total	$ 2,917

Note 11 - Madryn Debt and Con_3

Note 11 - Madryn Debt and Convertible Notes (Details Textual) - USD ($) $ / shares in Units, $ in Thousands					3 Months Ended		9 Months Ended
	Sep. 11, 2024	Jul. 26, 2024	Oct. 04, 2023	Dec. 09, 2020	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Jul. 29, 2024	Apr. 23, 2024
Gain (Loss) on Extinguishment of Debt					$ (454)	$ 0	$ (11,355)	$ 0
Interest Expense, Debt					1,487	1,539	5,394	4,469
Series X Convertible Preferred Stock [Member][
Preferred Stock, Par or Stated Value Per Share (in dollars per share)			$ 0.0001
Shares Issued, Price Per Share (in dollars per share)			$ 20.1
Madryn Noteholders [Member] | Conversion from Madryn Noteholders, Outstanding Debt Converted to Convertible Instruments [Member] | Series X Convertible Preferred Stock [Member][
Debt Conversion, Original Debt, Amount			$ 26,695
Debt Conversion, Converted Instrument, Amount			$ 22,792
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)			248,755
Gain (Loss) on Extinguishment of Debt			$ (2,000)
Madryn Credit Agreement [Member]
Repayments of Debt				$ 42,500
Secured Subordinated Convertible Notes [Member]
Long-Term Debt					30,917		30,917
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member]
Debt Instrument, Face Amount				$ 26,700
Preferred Stock, Par or Stated Value Per Share (in dollars per share)			$ 8.5
Debt Instrument, Default, Increase in Interest Rate			4%
Long-Term Debt, Gross					26,200		26,200
Interest Expense, Debt					903	557	2,598	1,631
Repayments of Long-Term Debt					0		0
Debt Instrument, Maturity Date			Dec. 09, 2025
Bridge Financing [Member] | Madryn Noteholders [Member]
Debt Instrument, Face Amount										$ 2,238
Repayments of Long-Term Debt					0	$ 0	0	$ 0
Debt Instrument, Maximum Additional Principal									$ 3,000	$ 2,762
Debt Instrument, Interest Rate, Stated Percentage										12%
Debt Instrument, Default Interest Rate										15%
Proceeds from Issuance of Debt	$ 1,000	$ 1,000
Long-Term Debt					$ 4,400		$ 4,400

Note 11 - Madryn Long-term Debt

Note 11 - Madryn Long-term Debt and Convertible Notes - Scheduled Payments (Details) - Secured Subordinated Convertible Notes [Member] $ in Thousands	Sep. 30, 2024 USD ($)
2024	$ 0
2025	30,917
Total	$ 30,917

Note 12 - Credit Facility (Deta

Note 12 - Credit Facility (Details Textual) - USD ($) $ in Millions	Jan. 18, 2024	Aug. 26, 2021	Dec. 09, 2020
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]	Secured Overnight Financing Rate (SOFR) [Member]	London Interbank Offered Rate [Member]
City National Bank of Florida [Member] | CNB Note [Member]
Debt Instrument, Face Amount		$ 5
Debt Instrument, Maturity Date		Jul. 24, 2023
City National Bank of Florida [Member] | Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity		$ 5	$ 10
Debt Instrument, Basis Spread on Variable Rate		3.25%
Debt Instrument, LIBOR Floor		0.50%
Line of Credit Facility, Minimum Deposit Required		$ 1.5	$ 3

Note 13 - EW Convertible Note_2

Note 13 - EW Convertible Notes (Details Textual) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended		9 Months Ended
	Jan. 18, 2024	Aug. 26, 2021	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Proceeds from Convertible Debt					$ 1,607	$ 0
Interest Expense, Debt			$ 1,487	$ 1,539	5,394	$ 4,469
Derivative Liability			327		327
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]	Secured Overnight Financing Rate (SOFR) [Member]	London Interbank Offered Rate [Member]
The 2024 Notes [Member] | EW Investors [Member]
Proceeds from Convertible Debt	$ 2,000
Debt Instrument, Basis Spread on Variable Rate	8.50%
Debt Instrument, Default, Increase in Interest Rate	4%
Debt Instrument, Convertible, Conversion Ratio	799.3605
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 1.251
Long-Term Debt, Gross			2,200		2,200
Interest Expense, Debt			74		200
Derivative Liability	$ 900		300		300
Repayments of Convertible Debt			$ 0		$ 0
Debt Instrument, Maturity Date	Dec. 09, 2025

Note 13 - EW Convertible Note_3

Note 13 - EW Convertible Notes - Scheduled Payments (Details) - The 2024 Notes [Member] - EW Investors [Member] $ in Thousands	Sep. 30, 2024 USD ($)
2024	$ 0
2025	2,590
Total	$ 2,590

Note 14 - Common Stock Reserv_3

Note 14 - Common Stock Reserved for Issuance - Common Stock Reserved for Issuance (Details) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Outstanding stock options and RSUs (in dollars per share)	$ 993,327	$ 981,834
Shares reserved for future option grants and RSUs (in shares)	308,878	99,580
Total common stock reserved for issuance (in shares)	98,529,412	18,887,958
Lincoln Park [Member]
Total common stock reserved for issuance (in shares)	0	711,180
Madryn Noteholders [Member]
Total common stock reserved for issuance (in shares)	1,300,000	1,300,000
EW Investors [Member]
Total common stock reserved for issuance (in shares)	2,100,000	0
Non-Voting Preferred Stock [Member]
Shares reserved for conversion of future preferred share issuance (in shares)	5,596,273	5,844,213
Common Stock [Member]
Outstanding common stock warrants (in shares)	1,936,920	1,061,930
Preferred Stock [Member]
Preferred shares (in shares)	86,294,014	8,889,221

Note 15 - Stockholders' Equit_2

Note 15 - Stockholders' Equity (Details Textual)										1 Months Ended			3 Months Ended					9 Months Ended		12 Months Ended	17 Months Ended	24 Months Ended
	Feb. 27, 2024 USD ($) $ / shares shares	Oct. 20, 2023 USD ($) shares	Oct. 04, 2023 $ / shares shares	Sep. 08, 2023 USD ($) shares	Jul. 12, 2023 USD ($) shares	May 15, 2023 USD ($) shares	May 11, 2023	May 10, 2023	Jul. 12, 2022 USD ($) $ / shares shares	Nov. 30, 2022 USD ($) $ / shares shares	Nov. 30, 2017	Nov. 30, 2010	Sep. 30, 2024 USD ($) $ / shares shares	Mar. 31, 2024 shares	Sep. 30, 2023 USD ($) $ / shares	Jun. 30, 2023 shares	Mar. 31, 2023 shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Sep. 26, 2024 shares	May 24, 2024 USD ($) shares	May 31, 2023 USD ($) $ / shares	Jun. 16, 2020 USD ($) $ / shares shares
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares													$ 0.0001					$ 0.0001			$ 0.0001
Proceeds from Issuance of Common Stock | $																		$ 10,000	$ 1,109,000
Proceeds from Issuance of Private Placement | $																		$ 0	4,509,000
Common Stock, Capital Shares Reserved for Future Issuance (in shares)													98,529,412					98,529,412			18,887,958
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | $													$ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value | $													$ 0		$ 0			$ 0	$ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares													$ 0		$ 1.9			$ 0.705	$ 2.82
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value | $													$ 255,000		$ 307,000			$ 892,000	$ 1,013,000
The 2010 Share Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)											10 years	7 years
Common Stock, Capital Shares Reserved for Future Issuance (in shares)													28,947					28,947			28,168
The 2019 Plan [Member]
Common Stock, Capital Shares Reserved for Future Issuance (in shares)													279,931					279,931			71,412
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)													30,000					30,000
Share-based Compensation Arrangement by Share-based Payment Award, Increase in Authorized Shares, Percentage of Outstanding Stock Maximum													4%
The 2024 Investor Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	817,748
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares	$ 1.34
Voting Preferred Stock [Member]
Preferred Stock, Liquidation Preference Per Share (in dollars per share) | $ / shares										$ 30
Preferred Stock, Convertible, Conversion Ratio										0.6667
Preferred Stock, Convertible, Volume Weighted Average Price Per Common Share (in dollars per share) | $ / shares										$ 18.75
Senior Preferred Stock [Member]
Preferred Stock, Convertible, Conversion Ratio						2.6667
Liquidation Preference, Multiplier						2.5
Conversion Price, Benchmark, Multiplier						2.75
Series X Convertible Preferred Stock [Member][
Shares Issued, Price Per Share (in dollars per share) | $ / shares			$ 20.1
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares			$ 0.0001
Preferred Stock, Convertible, Conversion Ratio			10
Preferred Stock, Shares Authorized (in shares)			400,000
Preferred Stock, Dividend Rate, Percentage			12.50%
Series Y Convertible Preferred Stock [Member]
Preferred Stock, Convertible, Conversion Ratio																								100
Preferred Stock, Shares Authorized (in shares)																							900,000	600,000
Preferred Stock, Convertible, Minimum Proceeds From Conversion | $																								$ 30,000,000
Common Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)														8,333		118,729	224,378
H.C. Wainwright & Co., LLC [Member] | Placement Agent Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	57,242
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares	$ 1.8313
Equity Purchase Agreement [Member] | Lincoln Park [Member]
Equity Purchase Agreement, Maximum Offering Amount | $																										$ 31,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares																										$ 0.0001
Equity Purchase Agreement, Maximum Shares Issuable (in shares)																										517,560
Equity Agreement, Maximum Percentage of Stock Outstanding																										19.99%
Equity Agreement, Minimum Average Purchase Price (in dollars per share) | $ / shares																										$ 59.6325
Maximum Percentage of Outstanding Stock, Beneficial Ownership																										9.99%
Stock Issued During Period, Shares, New Issues (in shares)																				26,666,000		229,139
Shares Issued, Price Per Share (in dollars per share) | $ / shares																						$ 40.5
Stock Issued During Period, Shares, Commitment Fee (in shares)																						13,971
Stock Issued During Period, Value, Commitment Fee | $																						$ 620,000
Deferred Offering Costs | $																				$ 0		$ 123,000
Proceeds from Issuance of Common Stock | $																				$ 272,000
LPC Purchase Agreement 2022 [Member] | Lincoln Park [Member]
Equity Purchase Agreement, Maximum Offering Amount | $									$ 11,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares									$ 0.0001
Equity Purchase Agreement, Maximum Shares Issuable (in shares)									858,224
Equity Agreement, Maximum Percentage of Stock Outstanding									19.99%
Maximum Percentage of Outstanding Stock, Beneficial Ownership									9.99%
Shares Issued, Price Per Share (in dollars per share) | $ / shares													$ 1.16					$ 1.16			$ 3.966
Stock Issued During Period, Shares, Commitment Fee (in shares)									45,701									8,333			776,452
Stock Issued During Period, Value, Commitment Fee | $									$ 330,000									$ 10,000			$ 3,080,000
The 2022 Private Placement [Member]
Proceeds from Issuance of Private Placement | $										$ 6,720,000
Payments of Stock Issuance Costs | $										$ 202,000
The 2022 Private Placement [Member] | Convertible Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)										3,185,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares										$ 0.0001
Preferred Stock, Convertible, Shares Issuable (in shares)										2,123,443
The 2022 Private Placement [Member] | Common Stock [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares										$ 0.0001
Stock Issued During Period, Shares, New Issues (in shares)										116,668
Multi-Tranche Private Placement 2023 [Member]
Equity Purchase Agreement, Maximum Offering Amount | $																									$ 9,000,000
Equity Purchase Agreement, Minimum Aggregate Purchase Amount Per Tranche | $																									$ 500,000
Multi-Tranche Private Placement 2023 [Member] | Senior Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)		502,513		292,398	500,000	280,899
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares																									$ 0.0001
Proceeds from Issuance of Preferred Stock and Preference Stock | $		$ 2,000,000		$ 1,000,000	$ 2,000,000	$ 2,000,000
Registered Direct Offering [Member]
Maximum Percentage of Outstanding Stock, Beneficial Ownership	4.99%
Stock Issued During Period, Shares, New Issues (in shares)	817,748
Shares Issued, Price Per Share (in dollars per share) | $ / shares	$ 1.465
Proceeds from Issuance or Sale of Equity | $	$ 1,200,000
Registered Direct Offering [Member] | H.C. Wainwright & Co., LLC [Member]
Placement Agent Fee, Percentage of Gross Proceeds	7%
Management Fee, Percentage of Gross Proceeds	1%
Maximum [Member] | Registered Direct Offering [Member]
Maximum Percentage of Outstanding Stock, Beneficial Ownership	9.99%
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio							15
Reverse Stock Split [Member] | Minimum [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio								5
Reverse Stock Split [Member] | Maximum [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio								15

Note 15 - Stockholders' Equit_3

Note 15 - Stockholders' Equity - Stock-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Total stock-based compensation	$ 239	$ 364	$ 817	$ 1,214
Cost of Sales [Member]
Total stock-based compensation	9	11	28	37
Selling and Marketing Expense [Member]
Total stock-based compensation	58	81	190	266
General and Administrative Expense [Member]
Total stock-based compensation	148	243	524	794
Research and Development Expense [Member]
Total stock-based compensation	$ 24	$ 29	$ 75	$ 117

Note 15 - Stockholders' Equit_4

Note 15 - Stockholders' Equity - Stock Options Assumptions (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Expected term (in years) (Year)		6 years	6 years	6 years
Risk-free interest rate	0%	4.33%	4.23%
Expected volatility	0%	42.29%	43.06%	42.94%
Expected dividend rate	0%	0%	0%	0%
Minimum [Member]
Risk-free interest rate				3.37%
Maximum [Member]
Risk-free interest rate				4.33%

Note 15 - Stockholders' Equit_5

Note 15 - Stockholders' Equity - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Outstanding, number of shares (in shares)	981,834
Outstanding, weighted average exercise price (in dollars per share)	$ 19.85
Outstanding, weighted average remaining contractual term (Year)	7 years 4 months 2 days	7 years 6 months 29 days
Options granted, number of shares (in shares)	82,000
Options granted, weighted average exercise price (in dollars per share)	$ 0.71
Options granted, aggregate intrinsic value	$ 0
Options exercised, number of shares (in shares)	0
Options exercised, weighted average exercise price (in dollars per share)	$ 0
Options forfeited/cancelled, number of shares (in shares)	(70,507)
Options forfeited/cancelled, weighted average exercise price (in dollars per share)	$ 33.79
Outstanding, number of shares (in shares)	993,327	981,834
Outstanding, weighted average exercise price (in dollars per share)	$ 17.28	$ 19.85
Outstanding, aggregate intrinsic value	$ 0
Exercisable, number of shares (in shares)	524,739
Exercisable, weighted average exercise price (in dollars per share)	$ 27.07
Exercisable, weighted average remaining contractual term (Year)	6 years 6 months 21 days
Exercisable, aggregate intrinsic value	$ 0
Expected to vest, number of shares (in shares)	468,588
Expected to vest, weighted average exercise price (in dollars per share)	$ 6.32
Expected to vest, weighted average remaining contractual term (Year)	8 years 2 months 19 days
Expected to vest, aggregate intrinsic value	$ 0

Note 15 - Stockholders' Equit_6

Note 15 - Stockholders' Equity - Stock Options Outstanding and Exercisable (Details)	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Options outstanding, number (in shares) | shares	993,327
Options outstanding, weighted average remaining contractual term (Year)	7 years 4 months 2 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 17.28
Options exercisable (in shares) | shares	524,739
Options exercisable, weighted average remaining contractual term (Year)	6 years 6 months 21 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 27.07
Range One [Member]
Options outstanding, number (in shares) | shares	952,221
Exercise price range, lower limit (in dollars per share)	$ 0.7051
Exercise price range, upper limit (in dollars per share)	$ 54.6
Options outstanding, weighted average remaining contractual term (Year)	7 years 6 months 7 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 13.24
Options exercisable (in shares) | shares	483,810
Options exercisable, weighted average remaining contractual term (Year)	6 years 10 months 2 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 19.99
Range Two [Member]
Options outstanding, number (in shares) | shares	38,947
Exercise price range, lower limit (in dollars per share)	$ 63.9
Exercise price range, upper limit (in dollars per share)	$ 119.25
Options outstanding, weighted average remaining contractual term (Year)	3 years 1 month 28 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 97.8
Options exercisable (in shares) | shares	38,770
Options exercisable, weighted average remaining contractual term (Year)	3 years 1 month 24 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 97.7
Range Three [Member]
Options outstanding, number (in shares) | shares	1,627
Exercise price range, lower limit (in dollars per share)	$ 186.75
Exercise price range, upper limit (in dollars per share)	$ 382.5
Options outstanding, weighted average remaining contractual term (Year)	3 years 11 months 26 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 271.15
Options exercisable (in shares) | shares	1,627
Options exercisable, weighted average remaining contractual term (Year)	3 years 11 months 26 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 271.15
Range Four [Member]
Options outstanding, number (in shares) | shares	263
Exercise price range, lower limit (in dollars per share)	$ 405
Exercise price range, upper limit (in dollars per share)	$ 438.75
Options outstanding, weighted average remaining contractual term (Year)	8 months 15 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 405.51
Options exercisable (in shares) | shares	263
Options exercisable, weighted average remaining contractual term (Year)	8 months 15 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 405.51
Range Five [Member]
Options outstanding, number (in shares) | shares	269
Exercise price range, lower limit (in dollars per share)	$ 650.25
Exercise price range, upper limit (in dollars per share)	$ 958.5
Options outstanding, weighted average remaining contractual term (Year)	3 years 8 months 12 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 727.38
Options exercisable (in shares) | shares	269
Options exercisable, weighted average remaining contractual term (Year)	3 years 8 months 12 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 727.38

Note 16 - Income Taxes (Details

Note 16 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Expense (Benefit)	$ (31)	$ (321)	$ 147	$ 103

Note 16 - Income Taxes - Reconc

Note 16 - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Loss before income taxes	$ (9,333)	$ (9,277)	$ (38,808)	$ (25,797)
Theoretical tax expense at the statutory rate (21% in 2024 and 2023)	(1,960)	(1,961)	(8,150)	(5,417)
Differences in jurisdictional tax rates	(437)	(417)	(1,807)	(965)
Valuation allowance	2,282	2,343	9,604	6,675
Non-deductible expenses	84	89	500	186
Other	0	(375)	0	(376)
Total income tax provision (recovery)	(31)	(321)	147	103
Net loss	$ (9,302)	$ (8,956)	$ (38,955)	$ (25,900)

Note 16 - Income Taxes - Reco_2

Note 16 - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details) (Parentheticals)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statutory Rate	21%	21%	21%	21%

Note 17 - Segment and Geograp_3

Note 17 - Segment and Geographic Information (Details Textual) $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Number of Reportable Segments	1
Number of Operating Segments	1
Leases [Member]
Sales with Typical Lease Terms (Month)	36 months
System [Member]
Sales with Payment Terms (Month)	12 months
UNITED STATES
Long-Lived Assets	$ 6,028	$ 8,705
Non-US [Member]
Long-Lived Assets	$ 856	$ 1,063

Note 17 - Segment and Geograp_4

Note 17 - Segment and Geographic Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Total revenue	$ 15,007	$ 17,616	$ 49,068	$ 58,222
UNITED STATES
Total revenue	8,548	11,167	27,902	31,665
Non-US [Member]
Total revenue	$ 6,459	$ 6,449	$ 21,166	$ 26,557

Note 17 - Segment and Geograp_5

Note 17 - Segment and Geographic Information - Schedule of Revenue by Type (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Total revenue	$ 15,007	$ 17,616	$ 49,068	$ 58,222
Leases [Member]
Total revenue	2,684	4,368	10,732	14,440
System [Member]
Total revenue	8,898	9,834	28,020	33,212
Product [Member]
Total revenue	2,741	2,487	7,945	8,019
Service [Member]
Total revenue	$ 684	$ 927	$ 2,371	$ 2,551

Note 18 - Related Party Trans_2

Note 18 - Related Party Transactions (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2020	Jan. 01, 2021	Jan. 01, 2018
Revenue from Contract with Customer, Including Assessed Tax	$ 15,007	$ 17,616	$ 49,068	$ 58,222
Venus Concept Singapore Pte. Ltd (Venus Singapore) [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership					55%
Technicalbiomed Co., Ltd. (TBC) [Member]
Revenue from Contract with Customer, Including Assessed Tax			0	322
Venus Concept Singapore Pte. Ltd (Venus Singapore) [Member]
Revenue from Contract with Customer, Including Assessed Tax			$ 0	$ 122
Senior Officer [Member] | Technicalbiomed Co., Ltd. (TBC) [Member]
Equity Method Investment, Ownership Percentage							30%
Senior Officer [Member] | Venus Concept Singapore Pte. Ltd (Venus Singapore) [Member]
Equity Method Investment, Ownership Percentage						45%

Note 19 - Subsequent Events (De

Note 19 - Subsequent Events (Details Textual) - Bridge Financing [Member] - Madryn Noteholders [Member] - USD ($)	Nov. 01, 2024	Sep. 11, 2024	Jul. 26, 2024
Proceeds from Issuance of Debt		$ 1,000,000	$ 1,000,000
Subsequent Event [Member]
Proceeds from Issuance of Debt	$ 1,000,000